Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Ergocalciferol on Erythropoetin Stimulating Agent Dose

NCT01263028 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT01263028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01263028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Ergocalciferol on Erythropoetin Stimulating Agent Dose
Lead sponsor
Kaiser Permanente
Phase
Not applicable
Overall status
Terminated
Start date
August 31, 2010
Completion date
September 30, 2011
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease stages 3-5